Taiko Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3442200006
  • TKS: 4574
JPY
257.00
-1 (-0.39%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore

Dashboard

1

Poor Management Efficiency with a low ROE of 5.99%

  • The company has been able to generate a Return on Equity (avg) of 5.99% signifying low profitability per unit of shareholders funds
2

Weak Long Term Fundamental Strength with a -43.41% CAGR growth in Operating Profits over the last 5 years

3

Poor long term growth as Net Sales has grown by an annual rate of -21.72% and Operating profit at -43.41% over the last 5 years

 
4

Flat results in Jun 26

5

Underperformed the market in the last 1 year

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 13,824 Million (Small Cap)

stock-summary
P/E

32.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.41

stock-summary
Return on Equity

5.06%

stock-summary
Price to Book

1.67

Revenue and Profits:
Net Sales:
1,720 Million
(Quarterly Results - Jun 2026)
Net Profit:
139 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.1%
0%
-4.1%
6 Months
-15.18%
0%
-15.18%
1 Year
-16.29%
0%
-16.29%
2 Years
-34.44%
0%
-34.44%
3 Years
-27.4%
0%
-27.4%
4 Years
-57.38%
0%
-57.38%
5 Years
-73.26%
0%
-73.26%

Taiko Pharmaceutical Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-21.72%
EBIT Growth (5y)
-43.41%
EBIT to Interest (avg)
-178.85
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.38
Sales to Capital Employed (avg)
0.64
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
17.96%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.17%
ROE (avg)
5.99%

Valuation key factors

Factor
Value
P/E Ratio
32
Industry P/E
Price to Book Value
1.61
EV to EBIT
31.25
EV to EBITDA
16.65
EV to Capital Employed
2.04
EV to Sales
1.61
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
6.53%
ROE (Latest)
5.06%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 87.77% vs -57.75% in Mar 2026",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 246.32% vs -137.40% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,720.00",
          "val2": "916.00",
          "chgp": "87.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "190.00",
          "val2": "-24.00",
          "chgp": "891.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "139.00",
          "val2": "-95.00",
          "chgp": "246.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "66.90%",
          "val2": "-105.90%",
          "chgp": "17.28%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 1.67% vs 2.81% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 2.78% vs 124.87% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6,397.00",
          "val2": "6,292.00",
          "chgp": "1.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "724.00",
          "val2": "886.00",
          "chgp": "-18.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.00",
          "val2": "8.00",
          "chgp": "-37.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "146.00",
          "val2": "-131.00",
          "chgp": "211.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "923.00",
          "val2": "898.00",
          "chgp": "2.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "71.80%",
          "val2": "100.10%",
          "chgp": "-2.83%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQstock-summary

Jun'26
Mar'26
Change(%)
Net Sales
1,720.00
916.00
87.77%
Operating Profit (PBDIT) excl Other Income
190.00
-24.00
891.67%
Interest
1.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
139.00
-95.00
246.32%
Operating Profit Margin (Excl OI)
66.90%
-105.90%
17.28%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2026 is 87.77% vs -57.75% in Mar 2026

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is 246.32% vs -137.40% in Mar 2026

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
6,397.00
6,292.00
1.67%
Operating Profit (PBDIT) excl Other Income
724.00
886.00
-18.28%
Interest
5.00
8.00
-37.50%
Exceptional Items
146.00
-131.00
211.45%
Consolidate Net Profit
923.00
898.00
2.78%
Operating Profit Margin (Excl OI)
71.80%
100.10%
-2.83%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 1.67% vs 2.81% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 2.78% vs 124.87% in Dec 2024

stock-summaryCompany CV
About Taiko Pharmaceutical Co., Ltd. stock-summary
stock-summary
Taiko Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Footer loading